Cargando…
TL-532, a novel specific Toll-like receptor 3 agonist rationally designed for targeting cancers: discovery process and biological characterization
Toll-like receptor 3 (TLR3) is an innate immune receptor that recognizes double-stranded RNA (dsRNA) and induces inflammation in immune and normal cells to initiate anti-microbial responses. TLR3 acts also as a death receptor only in cancer cells but not in their normal counterparts, making it an at...
Autores principales: | Thierry, Sylvain, Maadadi, Sarah, Berton, Aurore, Dimier, Laura, Perret, Clémence, Vey, Nelly, Ourfali, Saïd, Saccas, Mathilde, Caron, Solène, Boucard-Jourdin, Mathilde, Colombel, Marc, Werle, Bettina, Bonnin, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shared Science Publishers OG
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236204/ https://www.ncbi.nlm.nih.gov/pubmed/37275475 http://dx.doi.org/10.15698/mic2023.06.797 |
Ejemplares similares
-
A Chemically Defined TLR3 Agonist with Anticancer Activity
por: Le Naour, Julie, et al.
Publicado: (2023) -
Lymphatic embolization for the management of symptomatic pelvic lymphocele after radical prostatectomy with lymph node dissection: Report of two cases
por: Schneider, Gregoire, et al.
Publicado: (2020) -
Thymus-leukemia (TL) antigens of the mouse. Analysis of TL mRNA and TL cDNA TL+ and TL- strains
Publicado: (1985) -
Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytes
por: Lucifora, Julie, et al.
Publicado: (2018) -
TL antigen as a transplantation antigen recognized by TL-restricted cytotoxic T cells
Publicado: (1994)